Identification of novel GLUT inhibitors.

Bioorg Med Chem Lett

Bayer Pharma AG, Drug Discovery, Medicinal Chemistry 3, Muellerstraße 178, 13353 Berlin, Germany.

Published: April 2016

The compound class of 1H-pyrazolo[3,4-d]pyrimidines was identified using HTS as very potent inhibitors of facilitated glucose transporter 1 (GLUT1). Extensive structure-activity relationship studies (SAR) of each ring system of the molecular framework was established revealing essential structural motives (i.e., ortho-methoxy substituted benzene, piperazine and pyrimidine). The selectivity against GLUT2 was excellent and initial in vitro and in vivo pharmacokinetic (PK) studies are encouraging.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2016.02.050DOI Listing

Publication Analysis

Top Keywords

identification novel
4
novel glut
4
glut inhibitors
4
inhibitors compound
4
compound class
4
class 1h-pyrazolo[34-d]pyrimidines
4
1h-pyrazolo[34-d]pyrimidines identified
4
identified hts
4
hts potent
4
potent inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!